As basic science provides the means to push back the average life-expectancy of humans, the number of individuals with neurodegenerative disorders such as AD and PD will greatly increase. It is therefore imperative that we provide appropriately trained scientists now for the anticipated needs of the future. Because the continuing changes in the health care delivery system in this country constrain the clinician's time more and more to the clinic, their ability to pose questions relevant for the patient and test them in the laboratory has decreased. As a result, future biomedical research in neurodegenerative disorders will come to depend more and more on the basic scientist. In order to provide these basic scientists with the skills needed to address questions that are not only fundamental to the biology of neurodegenerative processes but appropriately applicable to the clinical setting as well, a new model for training is required. This continuing postdoctoral training program will provide such a model. By design, the trainees of this program will be continually exposed to the clinical arena. The proposed training program is designed to develop highly qualified post-doctoral fellows (Ph.D. or M.D./Ph.D.) in the research area of age-related neurodegenerative diseases. It is anticipated that the trainees will primarily be Ph.D.'s interested in enhancing their basic and preclinical research skills during a period of intensive research training. Training will involve hands-on basic research training in areas ranging from molecular biology to behavioral assessment of animals models of disease and the assessment of human pathology. This program is unique because fellows are exposed to the special problems unique to the clinician scientist, which should further enable them to focus their research on those areas most germaine to the health-science community. The program is designed: (1) to provide basic and preclinical scientific education with rigorous and specialized research training into the neurobiology of the age-related neurodegenerative disorders (e.g. Alzheimer's Disease and Parkinson's Disease), (2) to provide fellows with a broad-base of knowledge regarding the age-dependent neurodegenerative disorders, (3) to introduce and instruct fellows as to the major problems these disorders pose to the clinician/clinical researcher, and (4) to develop analytical skills that will aid the trainees in developing into independent scientists in health-related research.
The first aim will be accomplished by an apprenticeship under the tutelage of a senior basic-scientist preceptor. Research skills will be enhanced by elective rotations in other laboratories that have techniques or skills to offer trainees in the furthering of their research goals. Finally the program will provide a broad-base of knowledge on neurodegenerative disorders as well as other instruction important for enhancing the interpersonal and professional skills of our trainees.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Institutional National Research Service Award (T32)
Project #
5T32AG000257-09
Application #
7227488
Study Section
Special Emphasis Panel (ZAG1-ZIJ-6 (J1))
Program Officer
Snyder, Stephen D
Project Start
1997-06-15
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
9
Fiscal Year
2007
Total Cost
$115,906
Indirect Cost
Name
Rush University Medical Center
Department
Neurosciences
Type
Schools of Medicine
DUNS #
068610245
City
Chicago
State
IL
Country
United States
Zip Code
60612
Overk, Cassia R; Perez, Sylvia E; Ma, Chunqi et al. (2013) Sex steroid levels and AD-like pathology in 3xTgAD mice. J Neuroendocrinol 25:131-144
Overk, Cassia R; Lu, Pei-Yi; Wang, Yue-Ting et al. (2012) Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice. Neurobiol Dis 45:479-87
Trivedi, Mehul A; Stoub, Travis R; Murphy, Christopher M et al. (2011) Entorhinal cortex volume is associated with episodic memory related brain activation in normal aging and amnesic mild cognitive impairment. Brain Imaging Behav 5:126-36
Counts, Scott E; Mufson, Elliott J (2010) Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem 113:649-60
Overk, Cassia R; Felder, Christian C; Tu, Yuan et al. (2010) Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease. J Chem Neuroanat 40:63-70
Rogalski, E J; Murphy, C M; deToledo-Morrell, L et al. (2009) Changes in parahippocampal white matter integrity in amnestic mild cognitive impairment: a diffusion tensor imaging study. Behav Neurol 21:51-61
Overk, Cassia R; Kelley, Christy M; Mufson, Elliott J (2009) Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease. Neurobiol Dis 35:415-25
Trivedi, Mehul A; Murphy, Christopher M; Goetz, Celine et al. (2008) fMRI activation changes during successful episodic memory encoding and recognition in amnestic mild cognitive impairment relative to cognitively healthy older adults. Dement Geriatr Cogn Disord 26:123-37
Pitzer, Mark R; Sortwell, Caryl E; Daley, Brian F et al. (2003) Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells. Exp Neurol 182:435-45
Sendera, T J; Ma, S Y; Jaffar, S et al. (2000) Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome. J Neurochem 74:1185-96

Showing the most recent 10 out of 12 publications